clinicaltrialsarena1h
Replicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase I
The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
clinicaltrialsarena7h
US’ DHA launches platform trial to tackle PTSD in soldiers and veterans
The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...
clinicaltrialsarena7h
MSD commences Phase III trial of DLBCL treatment
MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...